Atrowide Eye Drops – Pediatric Use
In: Myopia
- Non-selective muscarinic receptor antagonists (M-antagonist) for the treatment of progressive myopia.
- Offers a modulated and sustained myopic rebound as compared to 0.5% and 0.1% atropine.
- Slows the growth of vitreous chamber depth, which in turn decelerates axial length increase.
- More effective in slowing myopia progression with fewer visual side effects as compared with higher doses of atropine.
